(No ratings)
Dr. Kenneth M. Heym, MD is a pediatric oncologist in Fort Worth, TX specializing in pediatric hematology. He graduated from Vanderbilt University School of Medicine. Dr. Kenneth M. Heym, MD is affiliated with Texas Health Resources, Cook Children's Medical Center, Cook Children's, Midland Health and Cook Children's Hematology and Oncology Center.
Midland Health
Dr. Kenneth M. Heym, MD graduated from Vanderbilt University School of Medicine. He completed residency at Morgan Stanley Children's Hospital. He is certified by the Board certifications: American Board of Pediatrics and has a state license in Texas.
Medical School: Vanderbilt University School of Medicine
Residency: Morgan Stanley Children's Hospital
Board Certification: Board certifications: American Board of Pediatrics
Licensed In: Texas
Dr. Kenneth M. Heym, MD is associated with these hospitals and organizations:
Dr. Kenneth M. Heym, MD appears to accept the following insurance providers: Cigna Healthcare of Texas, MultiPlan Inc/PHCS, Aetna, Galaxy Healthcare Network, EHN- Employers Health Network, Providence Health Alliance, First Health Network, United Healthcare PPO/EPO, Blue Cross Blue Shield of Texas PPO, HealthSmart Payors Organization/HealthSmart, Imagine Health, USA Managed Care Organizations, Baylor Scott and White Health Plan, Fort Worth Firefighters 440, HealthScope and Blue Cross Blue Shield HealthSelect of Texas.
According to our sources, Dr. Kenneth M. Heym, MD accepts the following insurance providers:
Dr. Kenneth M. Heym, MD does not have any reviews yet, be the first to leave a review of Dr. Kenneth M. Heym, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Kenneth M. Heym, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Novartis Pharmaceuticals Corporation |
$337
VIJOICE $241 |
KYMRIAH $13 |
$83 |
|
|---|---|---|---|---|
| Jazz Pharmaceuticals Inc. |
$153
RYLAZE $153 |
|||
| Pierre Fabre Pharmaceuticals, Inc. |
$130
Hemangeol $130 |
|||
| Shire North American Group Inc |
$122
Oncaspar $122 |
|||
| Servier Pharmaceuticals LLC |
$109
ASPARLAS $109 |
|||
| Other |
$156
GAMIFANT $53 |
FOUNDATIONONE LIQUID CDX $43 |
Blincyto $42 |
ADCETRIS $17 |
| Food and Beverage | $1,007 |
|---|
Dr. Kenneth M. Heym, MD has received 37 research payments totaling $2,842,462.
Dr. Kenneth Heym is extremely skilled and highly respected for their work in the fight against childhood cancer and blood disorders.